Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sudarshan Pharma Industries Ltd stock PB Ratio (=6.44) is close to 1-year high of 6.44.
The historical rank and industry rank for Sudarshan Pharma Industries's PB Ratio or its related term are showing as below:
BOM:543828'
s PB Ratio Range Over the Past 10 Years
Min: 3.87 Med: 5.4 Max: 8.99
Current: 5.8
During the past 10 years, Sudarshan Pharma Industries's highest PB Ratio was 8.99. The lowest was 3.87. And the median was 5.40.
BOM:543828's PB Ratio is ranked worse than 89.66% of 1577
companies
in the Chemicals industry
Industry Median: 1.72
vs BOM:543828: 5.80
During the past 12 months, Sudarshan Pharma Industries's average Book Value Per Share Growth Rate was 18.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -5.30% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Sudarshan Pharma Industries was 72.00% per year. The lowest was -55.90% per year. And the median was 15.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sudarshan Pharma Industries PB Ratio Related Terms
Sudarshan Pharma Industries PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Sudarshan Pharma Industries's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudarshan Pharma Industries PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sudarshan Pharma Industries's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sudarshan Pharma Industries (BOM:543828) has a PB Ratio of 5.00 as of Aug. 06, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sudarshan Pharma Industries and its competitors. This is near median its historical median of 5.40. Over the past decade, Sudarshan Pharma Industries' PB Ratio has ranged from 3.87 to 8.99. According to the industry distribution chart, Sudarshan Pharma Industries ranks #1414 out of 1577 companies in the Chemicals industry, placing it in the top 89.7%.
Is Sudarshan Pharma Industries' PB Ratio too high?
Sudarshan Pharma Industries' current PB Ratio of 5.00 is near median its 10-year median of 5.40. Over the past 10 years, this metric has ranged from a low of 3.87 to a high of 8.99. The Chemicals industry median PB Ratio is 1.72. Sudarshan Pharma Industries' value of 5.00 is 190.7% above this industry median. Based on the distribution chart, Sudarshan Pharma Industries ranks #1414 out of 1577 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Sudarshan Pharma Industries has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' PB Ratio compare to DOW?
According to the Chemicals industry distribution chart, Sudarshan Pharma Industries ranks #1414 out of 1577 companies for PB Ratio. This places Sudarshan Pharma Industries in the lower half of its industry. The industry median PB Ratio is 1.72. Sudarshan Pharma Industries' value of 5.00 is 190.7% above this benchmark. Historically, Sudarshan Pharma Industries' own PB Ratio has ranged from 3.87 to 8.99 over the past decade. While the company's 10-year median is 5.40 vs. the industry median of 1.72, Sudarshan Pharma Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.72, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudarshan Pharma Industries's current PB Ratio of 5.00 is 190.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sudarshan Pharma Industries and its competitors. For the Chemicals industry, the median PB Ratio is 1.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudarshan Pharma Industries's current PB Ratio is 5.00, which is near median its own 10-year median of 5.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.52, compared to a current price of ₹32.49 — trading 398.3% above its estimated fair value. The current PB Ratio is 5.00, which is near median its 10-year median of 5.40 and 190.7% above the Chemicals industry median of 1.72. Sudarshan Pharma Industries' overall GF Score™ is 69/100 with 14 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current PB Ratio is 5.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?
Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued.
The current stock price of ₹32.49 is trading 398.3% above its estimated GF Value™ of ₹6.52.
GuruFocus considers Sudarshan Pharma Industries to be Significantly Overvalued.
Key valuation signals for BOM:543828:
PB Ratio: 5.00 (near median its 10-year median of 5.40)
GF Value™: ₹6.52 vs. price of ₹32.49 (398.3% above fair value)
Industry Position: 190.7% above the Chemicals median (#1414 of 1577)
No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
69GF Score
Get the complete analysis for BOM:543828
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543828 has been successfully added to your 
